Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Cash & Equivalents (2016 - 2025)

cbdMD (YCBD) has disclosed Cash & Equivalents for 10 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 71.96% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, up 71.96% year-over-year, with the annual reading at $2.3 million for FY2025, 7.8% down from the prior year.
  • Cash & Equivalents hit $3.4 million in Q4 2025 for cbdMD, up from $2.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $26.4 million in Q3 2021 to a low of $1.1 million in Q2 2025.
  • Historically, Cash & Equivalents has averaged $7.4 million across 5 years, with a median of $2.6 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: surged 78.16% in 2021 and later tumbled 87.11% in 2023.
  • Year by year, Cash & Equivalents stood at $19.7 million in 2021, then plummeted by 82.98% to $3.4 million in 2022, then plummeted by 55.11% to $1.5 million in 2023, then soared by 30.92% to $2.0 million in 2024, then soared by 71.96% to $3.4 million in 2025.
  • Business Quant data shows Cash & Equivalents for YCBD at $3.4 million in Q4 2025, $2.3 million in Q3 2025, and $1.1 million in Q2 2025.